Will HPV Self-Collection Help Prevent Cervical Cancer?
In this episode of Clinical Lab Chat, we discuss what sample self-collection means for the diagnosis and treatment of HPV and cervical cancer.
In this episode of Clinical Lab Chat, we discuss what sample self-collection means for the diagnosis and treatment of HPV and cervical cancer.
In this episode of Clinical Lab Chat, we presented the CEO of Senzo a challenge—is it possible to create a “perfect” diagnostic test?
CLP’s director of business intelligence, Chris Wolski, sits down with Opentrons CEO Jonathan Brennan-Badal to discuss all things robotic.
CLP’s Director of Business Intelligence, Chris Wolski, spoke with Judit Giró Benet, co-founder and CEO of The Blue Box, for an in-depth discussion on breast cancer diagnostics, with a focus on non-invasive testing. Topics touched on during their conversation include using urine to identify breast cancer biomarkers; the distinctions between mammographies and liquid biopsies for cancer detection; and more.
Read MoreDiscover the latest insights on food allergies in the U.S. on Clinical Lab Chat! Join Chris Wolski, CLP’s Director of Business Intelligence, in a conversation with Jessica Murphy, MLS(ASCP)CM, from Thermo Fisher Scientific. They delve into:
The surge in food allergies among Americans and its causes.
The game-changing impact of home testing on allergy detection (and its challenges).
The crucial role of primary care doctors in allergy testing.
The promise of precise allergy testing for better patient care.
Why clinical labs remain vital for allergy diagnostics.
A glimpse into the future of allergy testing in the next 5-10 years. Don’t miss it!
XiFin has added new features and insights to its Lab Volume Index (LVI), with a deeper dive in the post-pandemic diagnostic landscape.
Read MoreIn its second annual Wage and Morale Survey, Lighthouse Lab Services found improvements in wages and satisfaction, but more can be done.
Read MoreLearn about dependable noninvasive H. pylori diagnostic testing solutions, like the BreathID®...
Read MoreChris Wolski, CLP’s director of Business Intelligence, David West, CEO of Proscia, and Lou Welebob, vice president and general manager of pathology at Agilent, take a deep dive into the big challenges facing clinical labs today.
Read MoreChris Wolski, has a wide-ranging discussion with Jeff Andrews, MD, FRCSC, vice president of Medical Affairs for BD, about BD’s recent STI health survey and what the findings mean for women’s health and their access to care.
Read MoreIn this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home testing improves healthcare access, and the win-win-win it brings to clinical laboratories.
Read MoreWhile the concept of diagnostic windows has been developed in cancer research, this study examines whether it is relevant for other diseases.
Read MoreIn this episode of Clinical Lab Chat, Chris Wolski meets the Texas A&M team behind what could be an effective, highly sensitive test for Lyme disease. Artem Rogovskky, PhD, ACVM, and Dmitry Kurouski, PhD, outline why Lyme disease is a diagnostic challenge and their work on developing a Lyme disease test using Raman spectroscopy.
Read MoreBioSPME (Bioanalytical Solid Phase MicroExtraction), has been developed to provide a high throughput automatable cleaner sample
Read MoreChris Wolski and Prasanth Perugupalli, chief product officer for Pramana, tackle why there have been delays in pathology labs adopting digital solutions, the business case for digital pathology, how it can change laboratory workflows, and what the future holds for digital pathology.
Read MoreThe cost of returning to normal activities may not only be a spike in COVID and the more common coronavirus the “common” cold, but influenza. Testing for both coronaviruses and influenza should be standard operating procedure at the first sign of symptoms.
Read MoreBruker launched PhenoRisk PACS RuO, a research-use-only NMR test for molecular phenomics research on Long COVID patients’ blood samples.
Read MoreBio-Techne introduced three novel TSA Vivid Fluorophores for highly sensitive fluorescent detection of RNAs and proteins.
Read More